BDSX
BIODESIX INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$29.20
+1.35%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- -$0.74
- Revenue estimate
- $27.6M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.71
- EPS estimate
- -$0.90
- Revenue actual
- $26.9M
- Revenue estimate
- $26.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +14.2%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $31
- PT range
- $27 – $35
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.90 | -$0.71 | Beat 21.27% | $26.9M |
| May 4, 2026 | -$1.26 | -$0.81 | Beat 35.71% | $25.6M |
| Aug 7, 2025 | -$1.40 | -$1.60 | Miss -14.29% | $20.0M |
| Mar 3, 2025 | -$0.07 | -$0.06 | Beat 14.29% | $20.4M |
| Nov 1, 2024 | -$0.08 | -$0.07 | Beat 12.50% | $18.2M |
| Mar 1, 2024 | -$0.11 | -$0.10 | Beat 9.09% | $14.7M |
| May 11, 2023 | -$0.26 | -$0.24 | Beat 7.69% | $9.1M |
| Mar 6, 2023 | -$0.26 | -$0.28 | Miss -7.69% | $9.6M |
| Nov 3, 2022 | -$0.32 | -$0.34 | Miss -6.25% | $11.1M |
| Aug 4, 2022 | -$0.47 | -$0.40 | Beat 14.89% | $10.9M |
| Mar 14, 2022 | -$0.50 | -$0.49 | Beat 2.00% | $7.2M |
| Nov 15, 2021 | -$0.50 | -$0.50 | In line | $6.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026